silver norfloxacin
used in treatment of corneal ulcer
Networked: 5
relevant articles (1 outcomes,
1 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Related Diseases
1. | Ulcer
|
2. | Infections
|
3. | Corneal Ulcer
|
4. | Burns
05/01/1993
- " [Bacteriostatic effects of silver norfloxacin, silver sulfadiazine, and "moisture burn ointment"]." 11/01/1986
- " Therefore, Norfloxacin and, particularly, silver-Norfloxacin, warrant further development as topical anti-infective agents for use in treating burn patients." 11/01/1986
- " Norfloxacin and silver-norfloxacin as topical antimicrobial agents: results of in vitro susceptibility testing against bacteria and Candida sp isolated from burn patients." 01/01/1994
- " "Moist ointment", cream base, 1% silver sulfadiazine (Ag-SD) cream or 1.2% silver norfloxacin (Ag-FLX) cream is topically applied to the burn wounds at various time interval of 10 min, 8h, 24h, and 48h, after the inoculation of Pseudomonas aeruginosa. " 03/01/1993
- " [Comparison of topical therapeutic effect between silver norfloxacin (Ag-NFL) and silver sulfadiazine (Ag-SD) in treatment of pyocyaneous sepsis in burn rats]."
|
5. | Sepsis (Septicemia)
|
|
Related Drugs and Biologics
Related Therapies and Procedures